The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling |
Oh, Jisun
(Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University)
Yoon, Hyo-Jin (Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University) Jang, Jeong-Hoon (Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University) Kim, Do-Hee (Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University) Surh, Young-Joon (Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University) |
1 | Santini R, Pietrobono S, Pandolfi S, Montagnani V, D'Amico M, Penachioni JY, Vinci MC, Borgognoni L, Stecca B. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene 2014;33:4697-708. DOI |
2 | Xia P, Xu XY. PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015;5:1602-9. |
3 | Mehdizadeh A, Somi MH, Darabi M, Jabbarpour-Bonyadi M. Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. Mol Biol Rep 2016;43:107-16. DOI |
4 | Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010;102:789-95. DOI |
5 | Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007;129:465-72. DOI |
6 | Borah A, Raveendran S, Rochani A, Maekawa T, Kumar DS. Targeting selfrenewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 2015;4:e177. |
7 | Tommasi S, Mangia A, Lacalamita R, Bellizzi A, Fedele V, Chiriatti A, Thomssen C, Kendzierski N, Latorre A, Lorusso V, et al. Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. Int J Cancer 2007;120:2078-85. DOI |
8 | Liu W, Shen SM, Zhao XY, Chen GQ. Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol. 2012;3:165-78. |
9 | Vidal SJ, Rodriguez-Bravo V, Galsky M, Cordon-Cardo C, Domingo-Domenech J. Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene 2014;33:4451-63. DOI |
10 | Horwitz S. Taxol (paclitaxel): mechanisms of action. Ann Oncol 1993;5:S3-6. DOI |
11 | Samanta D, Gilkes DM, Chaturvedi P, Xiang L, Semenza GL. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci USA 2014;111:E5429-38. DOI |
12 | Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Investig 2004;113:175-9. DOI |
13 | Rybak AP, Tang D. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cell Signal 2013;25:2734-42. DOI |
14 | Wicha MS. Targeting self-renewal, an Achilles' heel of cancer stem cells. Nat Med 2014;20:14-5. DOI |
15 | Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, Frelin C, Davis T, Cao LX, Baiazitov R, Du W, Sydorenko N, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 2014;20:29-36. DOI |
16 | Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011;9:298-310. DOI |
17 | Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 2014;15:243-56. DOI |
18 | Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006;3:177-85. DOI |
19 | Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA,NamKY, Arnason JT, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46-56. DOI |
20 | Sumiyoshi M, Sakanaka M, Kimura Y. Effects of red ginseng extract on allergic reactions to food in Balb/c mice. J Ethnopharmacol 2010;132:206-12. DOI |
21 | Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63:1702-4. DOI |
22 | Qiu XM, Bai X, Jiang HF, He P, Wang JH. 20(S)-Ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/Akt pathways. Anti-cancer Drugs 2014;25:1072-80. DOI |
23 | Philip B, Ito K, Moreno-Sanchez R, Ralph SJ. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis 2013;34:1699-707. DOI |
24 | Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay R, Engh J, Iwama T, Kunisada T, Kassam A. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1a. Oncogene 2009;28:3949-59. DOI |
25 | Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. DOI |
26 | Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 2014;11:101-15. |
27 | Lee SM, Bae BS, Park HW, Ahn NG, Cho BG, Cho YL, Kwak YS. Characterization of Korean red ginseng (Panax ginseng Meyer): history, preparation method, and chemical composition. J Ginseng Res. 2015;39:384-91. DOI |
28 | Dong H, Bai LP, Wong VKW, Zhou H, Wang JR, Liu Y, Jiang ZH, Liu L. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives. Molecules 2011;16:10619-30. DOI |
29 | He BC, Gao JL, Luo X, Luo J, Shen J, Wang L, Zhou Q, Wang Y-T, Luu HH, Haydon RC. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of -catenin signaling. Int J Oncol 2011;38:437-45. DOI |
30 | Kim DH, Kim JH, Kim EH, Na HK, Cha YN, Chung JH, Surh YJ. 15-Deoxy-D12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Carcinogenesis 2009;30:645-54. DOI |
31 | Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res 2009;32:755-65. DOI |
32 | Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol 2012;3:25. DOI |
33 | Liu T, Zhao L, Hou H, Ding L, Chen W, Li X. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals. Tumour Biol 2017:39. |
34 | Kim SM, Lee SY, Cho JS, Son SM, Choi SS, Yun YP, Yoo HS, Yoon DY, Oh KW, Han SB, et al. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of . Eur J Pharmacol 2010;631:1-9. DOI |
35 | Lee YJ, Lee S, Ho JN, Byun S-S, Hong SK, Lee SE, Lee E. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin-resistant bladder tumor cell line. Oncol Rep 2014;32:1803-8. DOI |
36 | Chung SS, Vadgama JV. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3- signaling. Anticancer Res 2015;35:39-46. |
37 | Fan PH, Fan SJ, Wang H, Mao J, Shi Y, Ibrahim MM, Ma W, Yu XT, Hou ZH, Wang B, et al. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Res Ther 2013;4:1. DOI |
38 | Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y, Cao L, Liu Z, Jia C. Ginsenoside Rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem 2015;36:499-508. DOI |
39 | Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005;5:899-904. DOI |
40 | Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007;18:460-6. DOI |
41 | Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M. Cancer stem cell markers in common cancers-therapeutic implications. Trends in Mol Med 2008;14:450-60. DOI |
42 | Deng L, Xu J, Wang D, Liu S. Self-renewal pathways in mammary stem cells and carcinogenesis. Cancer stem cells: emerging concepts and future perspectives in translational oncology. Springer; 2015. p. 155-74. |
43 | Piva M, Domenici G, Iriondo O, Rabano M, Simoes BM, Comaills V, Barredo I, Lopez-Ruiz JA, Zabalza I, Kypta R, et al. Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med 2014;6:66-79. DOI |
44 | Wang MC, Li CL, Cui J, Jiao M, Wu T, Jing L, Nan KJ. BMI-1, a promising therapeutic target for human cancer. Oncol Lett 2015;10:583-8. DOI |
45 | Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 2012;30:372-8. DOI |
46 | Lee SY, Kim GT, Roh SH, Song J-S, Kim H-J, Hong S-S, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20(S)-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-6. DOI |
47 | O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16:3113-20. DOI |
48 | Liu AF, Yu XY, Liu SR. Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer 2013;32:483-7. |
49 | Hong CE, Lyu SY. Anti-inflammatory and Anti-oxidative effects of Korean red ginseng extract in human keratinocytes. Immune Netw 2011;11:42-9. DOI |
50 | Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucc S, Di Fiore PP, Pelicci PG. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell. 2009;138:1083-95. DOI |
51 | Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555-67. DOI |
52 | Kim BM, Kim DH, Park JH, Na HK, Surh YJ. Ginsenoside Rg3 induces apoptosis of human breast cancer (MDA-MB-231) cells. J Cancer Prev 2013;18:177-85. DOI |
53 | Wang R, Lv Q, Meng W, Tan Q, Zhang S, Mo X, Yang X. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J Thorac Dis 2014;6:829-37. |
54 | Kim DH, Surh YJ. Chemopreventive and therapeutic potential of phytochemicals targeting cancer ctem cells. Curr Pharm Rep 2015;1:302-11. DOI |
55 | Lee HJ, Kim JS, Song MS, Seo HS, Moon C, Kim JC, Jo SK, Jang JS, Kim SH. Photoprotective effect of red ginseng against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Phytother Res 2009;23:399-403. DOI |
56 | Tian L, Shen D, Li X, Shan X, Wang X, Yan Q, Liu J. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4. Oncotarget 2016;7:1619-32. DOI |
57 | Park IK, Qian DL, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-5. DOI |
58 | Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063-71. DOI |